Why have numerous phase 3 clinical trials failed despite advances in understanding AD pathobiology?

Analysis ID: SDA-2026-04-12-gap-debate-20260410-145418-c1527e7b | Domain: neurodegeneration | Status: completed | Created: 2026-04-12T16:27:18.738472

Top Hypotheses (1 total)

#1 NLRP3 Inflammasome Blockade as Upstream Intervention to Prevent SASP Amplification

0.533

NLRP3

**Background and Rationale** The NLRP3 inflammasome has emerged as a critical upstream regulator of neuroinflammation in age-related neurodegenerative diseases, particularly Alzheimer's disease and r

← Back to all analyses